Carolyne Zimmermann - 07 Jun 2021 Form 4 Insider Report for 4D Molecular Therapeutics Inc. (FDMT)

Role
Chief Business Officer
Signature
/s/ August J. Moretti, Attorney-in-Fact for Carolyne Zimmermann
Issuer symbol
FDMT
Transactions as of
07 Jun 2021
Net transactions value
$0
Form type
4
Filing time
09 Jun 2021, 20:28:24 UTC
Next filing
03 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FDMT Stock Option (Right to Buy) Award $0 +60,000 $0.000000 60,000 07 Jun 2021 Common Stock 60,000 $26.83 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest with respect to 25% of the total number of the underlying shares on June 7, 2022, and the remaining shares will vest in equal monthly installments over the following three-year period, such that the stock option will be fully vested on June 7, 2025, subject to the Reporting Person continuing to be a service provider to Issuer through each vesting date.